Premium
Hepatitis C virus‐core and non structural proteins lead to different effects on cellular antioxidant defenses
Author(s) -
Abdalla Maher Y.,
Ahmad Iman M.,
Spitz Douglas R.,
Schmidt Warren N.,
Britigan Bradley E.
Publication year - 2005
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.20388
Subject(s) - oxidative stress , antioxidant , glutathione , hepatitis c virus , hepatocyte , thioredoxin , catalase , heme oxygenase , biology , enzyme , heme , biochemistry , chemistry , virology , virus , in vitro
Chronic hepatitis C virus (HCV) infection leads to increased oxidative stress in the liver. Hepatic antioxidant enzymes provide an important line of defense against oxidative injury. To understand the antioxidant responses of hepatocytes to different HCV proteins, we compared changes in antioxidative enzymes in HCV‐core and HCV‐nonstructural protein expressing hepatocyte cell lines. We found that expression of HCV‐core protein in hepatocyte cell lines leads to increased oxidative stress as determined by increased in the oxidant‐sensitive probe 5‐(and‐6)‐chloromethyl‐2′,7′‐dichlorodihydrofluorescein diacetate (CM‐DCFH 2 ) fluorescence, decreased reduced glutathione (GSH), and increased oxidation of thioredoxin (Trx). Although the expression of HCV‐nonstructural (HCV‐NS) proteins led to increased oxidative stress as well, the antioxidant enzymatic responses were different. Over‐expression of HCV‐NS proteins increased antioxidant enzymes (MnSOD and catalase), heme oxygenase‐1 (HO‐1), and GSH, indicating different mechanism(s) of prooxidative activity than HCV‐core protein. Our findings show that different HCV proteins induce different antioxidant defense responses in hepatocytes. These findings may facilitate understanding the interaction of different HCV proteins with infected liver cells and help identify possible factors contributing to hepatocyte damage during HCV infection. J. Med. Virol. 76:489–497, 2005. © 2005 Wiley‐Liss, Inc.